🇺🇸 FDA
Patent

US 10927193

Gellan gum-based hydrogels, methods and uses thereof

granted A61KA61K31/715A61K35/28

Quick answer

US patent 10927193 (Gellan gum-based hydrogels, methods and uses thereof) held by STEMMATTERS, BIOTECNOLOGIA E MEDICINA REGENERATIVA, S.A. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
STEMMATTERS, BIOTECNOLOGIA E MEDICINA REGENERATIVA, S.A.
Grant date
Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/715, A61K35/28, A61K9/0019